Terms: = Thyroid cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Clinical Outcome
15 results:
1. thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?
La Salvia A; Siciliani A; Rinzivillo M; Verrico M; Baldelli R; Puliani G; Modica R; Zanata I; Persano I; Fanciulli G; Bassi M; Mancini M; Bellino S; Giannetta E; Ibrahim M; Panzuto F; Brizzi MP; Faggiano A
Endocrine; 2024 Feb; 83(2):519-526. PubMed ID: 37775725
[TBL] [Abstract] [Full Text] [Related]
2. SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of ttf-1-Negative Lung Adenocarcinomas.
Tanaka I; Dayde D; Tai MC; Mori H; Solis LM; Tripathi SC; Fahrmann JF; Unver N; Parhy G; Jain R; Parra ER; Murakami Y; Aguilar-Bonavides C; Mino B; Celiktas M; Dhillon D; Casabar JP; Nakatochi M; Stingo F; Baladandayuthapani V; Wang H; Katayama H; Dennison JB; Lorenzi PL; Do KA; Fujimoto J; Behrens C; Ostrin EJ; Rodriguez-Canales J; Hase T; Fukui T; Kajino T; Kato S; Yatabe Y; Hosoda W; Kawaguchi K; Yokoi K; Chen-Yoshikawa TF; Hasegawa Y; Gazdar AF; Wistuba II; Hanash S; Taguchi A
J Natl Cancer Inst; 2022 Feb; 114(2):290-301. PubMed ID: 34524427
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological Features of Low-Grade thyroid-like Nasopharyngeal Papillary Adenocarcinoma.
Li M; Wei J; Yao X; Wang C
Cancer Res Treat; 2017 Jan; 49(1):213-218. PubMed ID: 27384157
[TBL] [Abstract] [Full Text] [Related]
4. Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
Pelosi G; Haspinger ER; Bimbatti M; Leone G; Paolini B; Fabbri A; Tamborini E; Perrone F; Testi A; Garassino M; Maisonneuve P; de Braud F; Pilotti S; Pastorino U
Int J Surg Pathol; 2014 Apr; 22(2):136-48. PubMed ID: 24326823
[TBL] [Abstract] [Full Text] [Related]
5. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
[TBL] [Abstract] [Full Text] [Related]
6. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
[TBL] [Abstract] [Full Text] [Related]
7. Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.
Solis LM; Behrens C; Raso MG; Lin HY; Kadara H; Yuan P; Galindo H; Tang X; Lee JJ; Kalhor N; Wistuba II; Moran CA
Cancer; 2012 Jun; 118(11):2889-99. PubMed ID: 22020674
[TBL] [Abstract] [Full Text] [Related]
8. clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment.
Chung KP; Huang YT; Chang YL; Yu CJ; Yang CH; Chang YC; Shih JY; Yang PC
Chest; 2012 Feb; 141(2):420-428. PubMed ID: 21799026
[TBL] [Abstract] [Full Text] [Related]
9. Pulmonary adenocarcinoma with microcystic histology and intratumoral heterogeneity of EGFR gene polymorphism.
Yeh YC; Chou TY
Histopathology; 2010 Jul; 57(1):112-20. PubMed ID: 20653783
[TBL] [Abstract] [Full Text] [Related]
10. An unusual case of low-grade tubulopapillary adenocarcinoma of the sinonasal tract.
Bansal A; Pradeep KE; Gumparthy KP
World J Surg Oncol; 2008 May; 6():54. PubMed ID: 18492272
[TBL] [Abstract] [Full Text] [Related]
11. Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.
Thompson LD; Wieneke JA; Heffess CS
Endocr Pathol; 2005; 16(4):331-48. PubMed ID: 16627920
[TBL] [Abstract] [Full Text] [Related]
12. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma.
Shah L; Walter KL; Borczuk AC; Kawut SM; Sonett JR; Gorenstein LA; Ginsburg ME; Steinglass KM; Powell CA
Cancer; 2004 Oct; 101(7):1632-8. PubMed ID: 15378500
[TBL] [Abstract] [Full Text] [Related]
13. Galectin-3 expression in non-small cell lung carcinoma.
Puglisi F; Minisini AM; Barbone F; Intersimone D; Aprile G; Puppin C; Damante G; Paron I; Tell G; Piga A; Di Loreto C
Cancer Lett; 2004 Aug; 212(2):233-9. PubMed ID: 15279903
[TBL] [Abstract] [Full Text] [Related]
14. Small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases.
Soriano P; Navarro S; Gil M; Llombart-Bosch A
Virchows Arch; 2004 Sep; 445(3):292-7. PubMed ID: 15248064
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.
Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C
Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618
[TBL] [Abstract] [Full Text] [Related]
